As year-end nears, pharma groups plump up their pipelines Bristol Myers Squibb, Sanofi, Pfizer, Roche, and Yarrow Bioscience all added to their pipelines this week in an end-of-year licensing deal flurry.

#BristolMyersSquibb #Sanofi #Pfizer #Roche #YarrowBioscience #RandDpipelines #HarbourBioMed #Genentech #AI #CarisLifeSciences #CarisDiscovery #ADEL #phase1testing #DrenBio #drugdiscovery #immunology #oncology #rheumatology #Gravesdisease #GeneSciencePharma #GenSci
zurl.co/Kyjjn

Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug Sanofi buys a drug from Dren Bio to claim a stake in the emerging field of deep B-cell depletion for autoimmune diseases.

NEWS: #Sanofi says it has reached an agreement with #DrenBio that would see it take control of autoimmune disease treatment DR-0201, a #bispecificantibody based myeloid cell engager with the potential to "reset the immune system."

pharmaphorum.com/news/sanofi-...